文献速递消化内镜消化道肿瘤与早癌

i-scan 电子染色内镜对结肠镜检查中腺瘤检出效果的影响

Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-06-20

该随机对照试验于2017年2月1日至12月31日纳入740例50–75岁门诊结直肠肿瘤筛查或监测患者,比较 i-scan 1 与高清白光结肠镜的腺瘤检出率。意向治疗分析显示 i-scan 1 组腺瘤检出率显著高于高清白光组(47.2% vs 37.7%,P=.01),效应主要来自右半结肠微小扁平腺瘤的检出改善。

要点

  • i-scan 1 组腺瘤检出率显著高于高清白光组(47.2% vs 37.7%,P=.01)。
  • 符合方案分析中 i-scan 1 组腺瘤检出率亦显著高于高清白光组(47.6% vs 37.2%,P=.005)。
  • i-scan 1 组肿瘤性病变检出率显著高于高清白光组(56.4% vs 46.1%,P=.005)。

核心结论

  • 在前瞻性随机试验中,i-scan 1 结肠镜组检出的腺瘤患者比例高于高清白光结肠镜组,该效应主要来自右半结肠微小扁平腺瘤检出的改善,i-scan 1 技术可能使部分内镜医师获益。

研究设计与样本

  • 前瞻性随机对照试验,2017年2月1日至12月31日纳入740例50–75岁接受结直肠肿瘤筛查或监测的门诊患者,随机接受 i-scan 1 或高清白光结肠镜。
  • 符合方案分析纳入 i-scan 1 组357例和高清白光组358例;主要结局为腺瘤检出率(至少1枚任意大小腺瘤的受试者比例)。

主要发现

  • 意向治疗分析中,i-scan 1 组腺瘤检出率为47.2%,显著高于高清白光组的37.7%(P=.01)。
  • 符合方案分析中,i-scan 1 组腺瘤检出率为47.6%,显著高于高清白光组的37.2%(P=.005),但该效应并非在所有内镜医师中一致。
  • 两组无蒂锯齿状息肉检出率无差异。
  • i-scan 1 组肿瘤性病变检出率为56.4%,显著高于高清白光组的46.1%(P=.005)。
  • 次要分析显示,腺瘤检出率的提高与右半结肠微小扁平腺瘤检出的改善相关。

临床怎么用

  • 原文结论指出 i-scan 1 技术可能使部分内镜医师获益。

局限性

  • 原文报告该效应并非在所有内镜医师中一致。
  • 原文结论使用「可能使部分内镜医师获益」的限定表述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: I-scan is an electronic chromoendoscopy technology that improves resolution of epithelial and mucosal surfaces and vessels. We performed a randomized controlled trial to compare detection of adenomas by i-scan vs standard high-definition white-light (HDWL) colonoscopy. METHODS: From February 1 through December 31, 2017, 740 outpatients (50-75 years old) undergoing screening and surveillance for colorectal neoplasia were randomly assigned to groups that received colonoscopies with i-scan 1 (surface and contrast enhancement) or HDWL. When lesions and polyps were detected, endoscopists could switch between i-scan 1 and HDWL imaging to confirm their finding; polyps were collected and analyzed by histology. The primary outcome was adenoma detection rate (ADR, proportion of subjects with at least 1 adenoma of any size); secondary outcomes included detection of sessile serrated polyps and neoplasias, along with location, size, and morphology of polyps. We performed intent to treat and per-protocol analyses (on 357 patients evaluated by i-scan and 358 evaluated by HDWL colonoscopy) to assess the primary and secondary outcomes. RESULTS: There were no differences in baseline characteristics between the groups. In the intent to treat analysis, the ADR was significantly higher in the i-scan 1 group (47.2%) than in the HDWL colonoscopy group (37.7%) (P = .01). In the per-protocol analysis, the ADR in the i-scan 1 group (47.6%) was also significantly higher than in the HDWL group (37.2%) (P = .005), but this effect was not consistent among all endoscopists. There was no difference between groups in detection of sessile serrated polyps. However, the rate of neoplasia detection was significantly higher in the i-scan 1 group (56.4%) than in the than the HDWL group (46.1%) (P = .005). In secondary analyses, the increase in ADR was associated with improved detection of diminutive flat adenomas in the right colon. CONCLUSION: In a prospective randomized trial, higher proportions of patients with adenomas were identified in a group that underwent colonoscopy with i-scan 1 than in a group evaluated by HDWL colonoscopy. This effect was mainly due to improved detection of diminutive, flat right sided adenomas. I-scan 1 technology may benefit some endoscopists. ClinicalTrials.gov no: NCT02811419.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kidambi TD, Terdiman JP, El-Nachef N, et al. Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy. Clin Gastroenterol Hepatol. 2018. PMID: 29935326. doi:10.1016/j.cgh.2018.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。